Literature DB >> 30318033

Shoulder pain cost-of-illness in patients referred for public orthopaedic care in Australia.

Darryn Marks1, Tracy Comans2, Leanne Bisset3, Michael Thomas1, Paul A Scuffham4.   

Abstract

Objective The aim of this study was to calculate the societal economic burden of shoulder pain in patients on the orthopaedic waiting list at an Australian public hospital and calculate the cost (from the government's perspective) of care delivered by the hospital for those patients. Methods A cost-of-illness analysis was undertaken in a cohort of 277 orthopaedic patients on the Gold Coast in Australia. Outcomes included a health care costs and impacts questionnaire, work absenteeism, presenteeism questionnaires (Work Limitations Questionnaire (WLQ) and Work Productivity and Activity Impairment Questionnaire (WPAI)) and hospital care provision over a 2-year period. Results The mean societal cost of healthcare and domestic support was AU$20.72 per day (AU$7563 annually) per patient on the orthopaedic waiting list. When absenteeism and presenteeism were included, the cost per patient who was employed was AU$38.04 per day (AU$13885 annually) calculated with the WLQ and AU$61.31 per day (AU$22378 annually) calculated with the WPAI. The mean per-patient cost to government of public hospital care was AU$2622 in Year 1 and AU$3835.78 (s.d. 4961.28) over 2 years. The surgical conversion rate was 22%, and 51% of hospital care cost was attributable to outpatient services. Conclusions Public orthopaedic shoulder waiting lists create a large economic burden for society; few referrals require surgery and just over half the hospital care costs are for out-patient services. New models of care that better manage shoulder pain and identify surgical candidates before orthopaedic referral could reduce this burden. What is known about the topic? Little is known about the cost of shoulder pain in Australia, or the cost of patients referred for public orthopaedic care. What does this paper add? This article quantifies the costs of shoulder pain and the value of lost production from shoulder pain. The time spent waiting for public hospital orthopaedic appointments and the costs associated with waiting demonstrate that the time spent on a waiting list is a key driver of the economic burden. What are the implications for practitioners? Greater resourcing to reduce public orthopaedic shoulder waiting lists may be helpful, but system change is also required. Earlier and more accurate identification of surgical cases could reduce inefficient referrals and improve hospital productivity. Collaboration between clinicians and policy makers is needed to design more economically efficient shoulder care.

Entities:  

Mesh:

Year:  2019        PMID: 30318033     DOI: 10.1071/AH17242

Source DB:  PubMed          Journal:  Aust Health Rev        ISSN: 0156-5788            Impact factor:   1.990


  4 in total

1.  Reflections on Innovative Interventional Pain-Relieving Procedures: Lessons Learned from Previous Mistakes.

Authors:  Zirong Zhao; Thomas M Larkin; Steven P Cohen
Journal:  Pain Med       Date:  2020-04-01       Impact factor: 3.750

2.  Clinical practice guidelines for the management of atraumatic shoulder conditions: protocol for a systematic review.

Authors:  Dana Yen Lin Lee; Romi Haas; Jason A Wallis; Denise A O'Connor; Rachelle Buchbinder
Journal:  BMJ Open       Date:  2021-04-07       Impact factor: 2.692

3.  Measurement properties of the Brazilian versions of Fear-Avoidance Beliefs Questionnaire and Tampa Scale of Kinesiophobia in individuals with shoulder pain.

Authors:  Danilo Harudy Kamonseki; Melina Nevoeiro Haik; Larissa Pechincha Ribeiro; Rafaela Firmino de Almeida; Lucas Araújo de Almeida; Carlos Luques Fonseca; Paula Rezende Camargo
Journal:  PLoS One       Date:  2021-12-01       Impact factor: 3.240

4.  Feasibility study: one year fortnightly follow-up of the evolution of supra-spinatus degeneration via text-messages.

Authors:  Karl Vincent; Olivier Gagey; Charlotte Leboeuf-Yde
Journal:  Chiropr Man Therap       Date:  2020-11-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.